Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-12 1:22 pm Unchanged | 13G | Amylyx Pharmaceuticals Inc. AMLX | VANGUARD GROUP INC | 3,089,645 4.530% | 0 (Unchanged) | View |
| 2024-11-04 10:56 am Sale | 13G | Amylyx Pharmaceuticals Inc. AMLX | VANGUARD GROUP INC | 3,089,645 4.530% | -2,185,921 (-41.43%) | View |
| 2024-10-25 5:38 pm Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | PERCEPTIVE ADVISORS LLC | 4,458,741 6.500% | 2,589,616 (+138.55%) | View |
| 2024-08-26 6:49 pm Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | TCG Crossover GP II LLC | 4,643,812 6.800% | 4,643,812 (New Position) | View |
| 2024-07-08 4:32 pm Sale | 13G | Amylyx Pharmaceuticals Inc. AMLX | BlackRock Inc. BLK | 2,669,741 3.900% | -1,332,593 (-33.30%) | View |
| 2024-03-11 08:44 am Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | Panacea Innovation Ltd | 4,200,000 6.200% | 4,200,000 (New Position) | View |
| 2024-02-14 4:36 pm Sale | 13G | Amylyx Pharmaceuticals Inc. AMLX | PERCEPTIVE ADVISORS LLC | 1,869,125 2.800% | -4,219,208 (-69.30%) | View |
| 2024-02-14 10:24 am Sale | 13G | Amylyx Pharmaceuticals Inc. AMLX | VIKING GLOBAL INVESTORS LP | 2,962,555 4.400% | -1,672,051 (-36.08%) | View |
| 2024-02-14 07:15 am Sale | 13G | Amylyx Pharmaceuticals Inc. AMLX | Point72 Asset Management L.P. | 3,202,381 4.700% | -268,310 (-7.73%) | View |
| 2024-02-13 4:58 pm Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | VANGUARD GROUP INC | 5,275,566 7.810% | 917,074 (+21.04%) | View |
| 2024-01-29 5:25 pm Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | BlackRock Inc. BLK | 4,002,334 5.900% | 385,408 (+10.66%) | View |
| 2023-12-11 4:15 pm Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | Point72 Asset Management L.P. | 3,470,691 5.100% | 3,470,691 (New Position) | View |
| 2023-10-04 4:19 pm Sale | 13D | Amylyx Pharmaceuticals Inc. AMLX | Morningside Venture Investments Ltd | 2,313,227 3.430% | -2,305,619 (-49.92%) | View |
| 2023-08-17 5:15 pm Sale | 13D | Amylyx Pharmaceuticals Inc. AMLX | Morningside Venture Investments Ltd | 4,618,846 6.860% | -4,000,000 (-46.41%) | View |
| 2023-06-09 3:54 pm Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | GOLDMAN SACHS GROUP INC GS | 3,653,782 5.400% | 3,653,782 (New Position) | View |
| 2023-04-03 4:43 pm Sale | 13D | Amylyx Pharmaceuticals Inc. AMLX | Morningside Venture Investments Ltd | 8,618,846 12.920% | -683,296 (-7.35%) | View |
| 2023-02-14 2:33 pm Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | PERCEPTIVE ADVISORS LLC | 6,088,333 9.200% | 3,116,920 (+104.90%) | View |
| 2023-02-14 1:18 pm Sale | 13G | Amylyx Pharmaceuticals Inc. AMLX | VIKING GLOBAL INVESTORS LP | 4,634,606 7.000% | -1,135,930 (-19.68%) | View |
| 2023-02-13 2:27 pm Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | BlackRock Inc. BLK | 3,616,926 5.500% | 3,616,926 (New Position) | View |
| 2023-02-09 11:07 am Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | VANGUARD GROUP INC | 4,358,492 6.580% | 4,358,492 (New Position) | View |